爱博医疗收盘上涨1.52%，滚动市盈率40.36倍，总市值152.60亿元

Company Overview - Aibo Medical's closing price on August 25 was 78.9 yuan, with an increase of 1.52%, resulting in a rolling PE ratio of 40.36 times and a total market value of 15.26 billion yuan [1] - The company ranks 77th in the medical device industry, which has an average PE ratio of 56.14 times and a median of 40.36 times [1] Institutional Holdings - As of the first quarter of 2025, 18 institutions hold shares in Aibo Medical, all of which are funds, with a total holding of 11.0688 million shares valued at 762 million yuan [1] Business Operations - Aibo Medical focuses on the independent research, production, sales, and related services of ophthalmic medical devices, with main products including artificial lenses, surgical products, orthokeratology lenses, myopia control products, contact lenses, and other vision care products [1] Financial Performance - In the latest quarterly report for Q1 2025, Aibo Medical achieved an operating revenue of 357 million yuan, representing a year-on-year increase of 15.07%, while net profit was 92.5581 million yuan, showing a year-on-year decrease of 10.05%, with a gross profit margin of 64.60% [1]